胚胎限制性母体IL-17A反应促进小鼠子代神经发育障碍
研究通过将转人IL-17A过表达与母体IL-17A受体缺陷相结合,建立PRIMA-17模型,使母体IL-17A仅通过胚胎限制性反应发挥作用;证实转基因IL-17A可穿过胎盘屏障,导致子代早期筑巢回取叫声减少及成年期焦虑样行为增加。
要点
- 母体IL-17A可穿过胎盘屏障并触发子代特定行为缺陷。
- 胚胎期IL-17A反应导致早期交流障碍,表现为筑巢回取叫声减少。
- 成年期IL-17A印记子代焦虑样行为增加。
核心结论
- 胚胎限制性IL-17A反应足以触发子代特定行为缺陷,PRIMA-17模型可用于研究小鼠神经功能缺陷。
研究设计与样本
- 研究将转人IL-17A过表达与母体IL-17A受体缺陷相结合,建立产前母体IL-17A印记模型(PRIMA-17模型),用于研究仅通过胚胎限制性IL-17A反应建立的产前印记。
主要发现
- 转基因IL-17A可穿过胎盘屏障,触发小鼠子代特定行为缺陷。
- 胚胎期IL-17A反应导致早期交流障碍,表现为筑巢回取叫声数量减少。
- 成年期IL-17A印记子代焦虑样行为增加。
临床怎么用
- 作者认为PRIMA-17模型是研究小鼠神经功能缺陷的有用工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prenatal imprinting to interleukin 17A (IL-17A) triggers behavioral disorders in offspring. However, reported models of maternal immune activation utilizing immunostimulants, lack specificity to elucidate the anatomical compartments of IL-17A's action and the distinct behavioral disturbances it causes. By combining transgenic IL-17A overexpression with maternal deficiency in its receptor, we established a novel model of prenatal imprinting to maternal IL-17A (acronym: PRIMA-17 model). This model allowed us to study prenatal imprinting established exclusively through embryo-restricted IL-17A responses. We demonstrated a transfer of transgenic IL-17A across the placental barrier, which triggered the development of selected behavioral deficits in mouse offspring. More specifically, embryonic responses to IL-17A resulted in communicative impairment in early-life measured by reduced numbers of nest retrieval calls. In adulthood, IL-17A-imprinted offspring displayed an increase in anxiety-like behavior. We advocate our PRIMA-17 model as a useful tool to study neurological deficits in mice.
引用
- Andruszewski D, Uhlfelder DC, Desiato G, et al. Embryo-restricted responses to maternal IL-17A promote neurodevelopmental disorders in mouse offspring. Mol Psychiatry. 2024. PMID: 39384965. doi:10.1038/s41380-024-02772-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。